Electrical Storm in Dilated Cardiomyopathy Treated Using Epicardial Radiofrequency Ablation As a First Line Therapy
Overview
Overview
Journal
Indian Heart J
Publisher
Elsevier
Specialty
Cardiology & Vascular Diseases
Date
2016 Oct 19
PMID
27751294
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
We report a patient with non-ischemic dilated cardiomyopathy and low left ventricular systolic function (28%) presenting with an electrical storm originated in epicardial scar and ablated by radiofrequency. This case report suggests that a strategy of epicardial catheter ablation is reasonable for the patient presenting with electrical storm related to structural disease with a low left ventricular ejection fraction.
References
1.
Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon R
. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000; 101(11):1297-302.
DOI: 10.1161/01.cir.101.11.1297.
View
2.
Siebels J, Kuck K
. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994; 127(4 Pt 2):1139-44.
DOI: 10.1016/0002-8703(94)90101-5.
View
3.
. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337(22):1576-83.
DOI: 10.1056/NEJM199711273372202.
View
4.
Kuck K, Cappato R, Siebels J, Ruppel R
. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102(7):748-54.
DOI: 10.1161/01.cir.102.7.748.
View
5.
Maury P, Baratto F, Zeppenfeld K, Klein G, Delacretaz E, Sacher F
. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%. Eur Heart J. 2014; 35(22):1479-85.
DOI: 10.1093/eurheartj/ehu040.
View